Total Payments
$7,918
2024 Payments
$2,276
Companies
23
Transactions
97
Medicare Patients
1,082
Medicare Billing
$84,969
Payment Breakdown by Category
Food & Beverage$2,796 (35.3%)
Consulting$2,288 (28.9%)
Gifts$1,926 (24.3%)
Other$712.50 (9.0%)
Travel$195.76 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,796 | 78 | 35.3% |
| Consulting Fee | $2,288 | 11 | 28.9% |
| Gift | $1,926 | 1 | 24.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $712.50 | 6 | 9.0% |
| Travel and Lodging | $195.76 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| VISIONARY OPTICS LLC | $1,926 | 1 | $0 (2017) |
| Tarsus Pharmaceuticals, Inc. | $1,446 | 15 | $0 (2024) |
| CooperVision Inc. | $803.42 | 15 | $0 (2023) |
| Johnson & Johnson Vision Care, Inc. | $764.45 | 15 | $0 (2024) |
| Avedro Inc. | $600.00 | 1 | $0 (2018) |
| Alcon Laboratories Inc | $426.92 | 7 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $281.71 | 9 | $0 (2024) |
| Oyster Point Pharma, Inc. | $243.01 | 4 | $0 (2023) |
| Dompe US, Inc. | $189.62 | 3 | $0 (2024) |
| Glaukos Corporation | $186.05 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,276 | 31 | Tarsus Pharmaceuticals, Inc. ($1,446) |
| 2023 | $310.56 | 9 | Oyster Point Pharma, Inc. ($144.91) |
| 2022 | $282.00 | 7 | Novartis Pharmaceuticals Corporation ($159.03) |
| 2021 | $243.91 | 6 | Johnson & Johnson Vision Care, Inc. ($163.30) |
| 2020 | $37.21 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($18.73) |
| 2019 | $529.71 | 9 | Sight Sciences, Inc. ($142.01) |
| 2018 | $1,271 | 15 | Avedro Inc. ($600.00) |
| 2017 | $2,967 | 18 | VISIONARY OPTICS LLC ($1,926) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $18.96 | General |
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $36.30 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $39.14 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/29/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $39.63 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $39.55 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/26/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/19/2024 | Johnson & Johnson Surgical Vision, Inc. | LIPIFLOW SYSTEM ACTIVATOR II (DISPOSABLE (Device) | Food and Beverage | In-kind items and services | $49.14 | General |
| 08/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Ophthalmology | ||||||
| 07/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/18/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $128.83 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $39.55 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.12 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/15/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 05/15/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $187.50 | General |
| 05/15/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $82.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/13/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/30/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $186.05 | General |
| Category: Corneal Health | ||||||
| 04/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/19/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $26.03 | General |
| 04/11/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $158.40 | General |
| 04/10/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 423 | 543 | $56,005 | $32,075 |
| 2022 | 9 | 322 | 480 | $41,130 | $24,438 |
| 2021 | 8 | 219 | 264 | $30,565 | $18,074 |
| 2020 | 4 | 118 | 132 | $17,020 | $10,383 |
Total Patients
1,082
Total Services
1,419
Medicare Billing
$84,969
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 107 | $16,050 | $10,745 | 66.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 110 | $13,200 | $7,875 | 59.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 75 | 75 | $11,250 | $7,010 | 62.3% |
| 92250 | Photography of the retina | Office | 2023 | 68 | 69 | $6,210 | $1,974 | 31.8% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 20 | 50 | $1,500 | $1,102 | 73.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 23 | $2,070 | $1,096 | 52.9% |
| 92134 | Imaging of retina | Office | 2023 | 27 | 30 | $1,800 | $833.39 | 46.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 11 | 16 | $2,000 | $681.12 | 34.1% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 20 | 49 | $1,225 | $553.70 | 45.2% |
| 92285 | Photography of content of eyes | Office | 2023 | 13 | 14 | $700.00 | $205.30 | 29.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 69 | 69 | $10,350 | $7,150 | 69.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 62 | $9,300 | $6,192 | 66.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 73 | $8,760 | $5,094 | 58.2% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 26 | 88 | $2,640 | $1,953 | 74.0% |
| 92250 | Photography of the retina | Office | 2022 | 46 | 47 | $4,230 | $1,383 | 32.7% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2022 | 26 | 86 | $2,150 | $978.82 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 19 | $1,710 | $771.09 | 45.1% |
| 92134 | Imaging of retina | Office | 2022 | 18 | 19 | $1,140 | $625.17 | 54.8% |
| 92285 | Photography of content of eyes | Office | 2022 | 17 | 17 | $850.00 | $291.06 | 34.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 70 | 72 | $10,800 | $6,531 | 60.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 47 | $7,030 | $4,798 | 68.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 43 | $5,020 | $2,910 | 58.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 15 | 18 | $2,280 | $1,239 | 54.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 21 | $1,890 | $976.20 | 51.7% |
| 92250 | Photography of the retina | Office | 2021 | 21 | 23 | $2,070 | $762.30 | 36.8% |
About Dr. Andrew Mcleod, O.D
Dr. Andrew Mcleod, O.D is a Optometrist healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275735888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Mcleod, O.D has received a total of $7,918 in payments from pharmaceutical and medical device companies, with $2,276 received in 2024. These payments were reported across 97 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,796).
As a Medicare-enrolled provider, Mcleod has provided services to 1,082 Medicare beneficiaries, totaling 1,419 services with total Medicare billing of $84,969. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Boston, MA
- Active Since 06/05/2007
- Last Updated 12/12/2024
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1275735888
Products in Payments
- Acuvue (Device) $738.42
- Photrexa (Drug) $600.00
- AIR OPTIX (Device) $426.92
- XDEMVY (Drug) $311.66
- Biofinity Contact Lens (Device) $246.63
- TYRVAYA (Drug) $243.01
- INFUSE (Device) $241.61
- XIIDRA (Drug) $207.48
- Non-Product Brand Specific (Device) $195.76
- OXERVATE (Drug) $189.62
- Clariti Contact Lens (Device) $187.50
- CE-marked KXLA system (Device) $186.05
- MyDay Contact Lens (Device) $173.53
- RESTASIS (Drug) $148.24
- TearCare (Device) $142.01
- DAILIES (Device) $117.12
- RXSIGHT CONTACT LENS (Device) $82.73
- LIPIFLOW SYSTEM ACTIVATOR II (DISPOSABLE (Device) $68.95
- ULTRA (Device) $66.86
- TearCare SmartLid (Device) $43.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Boston
Dr. Donald Korb, Od, OD
Optometrist — Payments: $1.5M
Optometrist $1.5M
Dr. Kristen Brown, O.d, O.D
Optometrist — Payments: $75,403
Optometrist $75,403
Dr. Jaclyn Garlich, Od, OD
Optometrist — Payments: $73,738
Optometrist $73,738
Dr. Timothy Bossie, O.d, O.D
Optometrist — Payments: $59,811
Optometrist $59,811
Xiaohong Zhou, Od, OD
Optometrist — Payments: $21,266
Optometrist $21,266
Dr. Jennifer Liao, Od, OD
Optometrist — Payments: $11,263
Optometrist $11,263